NO744456L - - Google Patents

Info

Publication number
NO744456L
NO744456L NO744456A NO744456A NO744456L NO 744456 L NO744456 L NO 744456L NO 744456 A NO744456 A NO 744456A NO 744456 A NO744456 A NO 744456A NO 744456 L NO744456 L NO 744456L
Authority
NO
Norway
Prior art keywords
formula
compounds
methoxy
ethyl
mixture
Prior art date
Application number
NO744456A
Other languages
English (en)
Norwegian (no)
Inventor
P Pfaeffli
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1768973A external-priority patent/CH588488A5/de
Priority claimed from CH162174A external-priority patent/CH596207A5/de
Priority claimed from CH176574A external-priority patent/CH593283A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO744456L publication Critical patent/NO744456L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO744456A 1973-12-18 1974-12-10 NO744456L (is")

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1768973A CH588488A5 (en) 1973-12-18 1973-12-18 Vincamine derivs for treating behaviour disorders - by ring closure of indoloquinolizine deriv
CH162174A CH596207A5 (en) 1974-02-06 1974-02-06 Vincamine derivs for treating behaviour disorders
CH176574A CH593283A5 (en) 1974-02-08 1974-02-08 Vincamine derivs for treating behaviour disorders - by ring closure of indoloquinolizine deriv

Publications (1)

Publication Number Publication Date
NO744456L true NO744456L (is") 1975-07-14

Family

ID=27173122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO744456A NO744456L (is") 1973-12-18 1974-12-10

Country Status (16)

Country Link
JP (1) JPS5817474B2 (is")
CA (1) CA1051899A (is")
DD (1) DD116043A5 (is")
DE (1) DE2458164A1 (is")
DK (1) DK139358B (is")
ES (3) ES432952A1 (is")
FI (1) FI59096C (is")
FR (1) FR2254342B1 (is")
GB (1) GB1492579A (is")
HK (1) HK53980A (is")
IE (1) IE40791B1 (is")
MY (1) MY8100186A (is")
NL (1) NL7416237A (is")
NO (1) NO744456L (is")
PH (1) PH12927A (is")
SE (1) SE422798B (is")

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2396759A1 (fr) * 1977-07-06 1979-02-02 Omnium Chimique Sa Nouveaux composes heterocycliques, derives de la vincamine, leur preparation et leur application comme medicaments, notamment dans le domaine des insuffisances cardio-circulatoires, cerebro-vasculaires ou respiratoires
HU177498B (en) * 1977-07-27 1981-10-28 Richter Gedeon Vegyeszet Process for preparing new vincinic acid and apovincinic acid esters
FR2423493A1 (fr) * 1977-10-19 1979-11-16 Omnium Chimique Sa Nouveaux composes heterocycliques derives de l'apo-vincamine, leur preparation et leur application comme medicaments, notamment dans le domaine des insuffisances cardio-circulatoires, cerebro-vasculaires et respiratoires
FR2407931A1 (fr) * 1977-11-02 1979-06-01 Synthelabo Derives de l'eburnamenine et leur application en therapeutique
JPS5493000A (en) * 1977-12-28 1979-07-23 Sandoz Ag Improvement of organic compound
DE2800063A1 (de) * 1978-01-02 1979-07-12 Sandoz Ag 10-bromvincamin, seine herstellung und verwendung
US4315011A (en) * 1978-07-12 1982-02-09 Richter Gedeon Vegyeszeti Gyar Rt. 1-Alkyl-9-bromohexahydroindolo quinolizium salts and use thereof to increase blood flow
FR2445328A1 (fr) * 1978-07-12 1980-07-25 Richter Gedeon Vegyeszet Derives du 14-oxo-e-homo-eburnane, leur procede de preparation et leur utilisation comme medicament
US4285949A (en) * 1978-12-11 1981-08-25 Omnichem Societe Anonyme Vincamine derivatives, their preparation and therapeutical use
HU177732B (en) * 1978-12-15 1981-12-28 Richter Gedeon Vegyeszet Process for producing 10-bromo-vincamine and acid additional salts thereof,and 10-bromo-14-epivincamine
HU180928B (en) * 1979-08-06 1983-05-30 Richter Gedeon Vegyeszet Process for preparing new brominated 15-hydroxy-e-homo-eburane derivatives
HU180929B (en) * 1979-08-13 1983-05-30 Richter Gedeon Vegyeszet Process for producing new bromo-vincamone derivatives
HU185305B (en) * 1981-08-23 1985-01-28 Richter Gedeon Vegyeszet Process for preparing vincine and apovincine
HU183326B (en) * 1981-02-11 1984-04-28 Richter Gedeon Vegyeszet Process for preparing new apovincaminol-3',4',5'-trimethoxy-benzoates substituted in the a ring and acid addition salts thereof
ES8604952A1 (es) * 1985-11-05 1986-03-16 Covex Sa Procedimiento para la preparacion de los compuestos 10-11 bromo-14,15-dihidro-14 b-hidroxi-(3x,16x)-eburnamenina-14- carboxilato de metilo
US4883876A (en) * 1987-09-07 1989-11-28 Taisho Pharmaceutical Co., Ltd. Acylated vincaminic acid derivatives

Also Published As

Publication number Publication date
CA1051899A (en) 1979-04-03
DK139358C (is") 1979-07-09
FI59096C (fi) 1981-06-10
IE40791L (en) 1975-06-18
DK639774A (is") 1975-08-25
SE422798B (sv) 1982-03-29
HK53980A (en) 1980-10-03
ES450740A1 (es) 1977-12-16
SE7415416L (is") 1975-06-19
MY8100186A (en) 1981-12-31
FR2254342A1 (is") 1975-07-11
JPS5817474B2 (ja) 1983-04-07
DE2458164C2 (is") 1991-04-18
DD116043A5 (is") 1975-11-05
AU7648374A (en) 1976-06-17
FI355274A7 (is") 1975-06-19
NL7416237A (nl) 1975-06-20
GB1492579A (en) 1977-11-23
FI59096B (fi) 1981-02-27
PH12927A (en) 1979-10-10
FR2254342B1 (is") 1978-07-21
JPS50105700A (is") 1975-08-20
ES450741A1 (es) 1978-03-16
DE2458164A1 (de) 1975-06-26
ES432952A1 (es) 1977-02-16
IE40791B1 (en) 1979-08-15
DK139358B (da) 1979-02-05

Similar Documents

Publication Publication Date Title
NO744456L (is")
JP2716146B2 (ja) 縮合インドール誘導体およびその製造方法
Grunwell et al. The formal oxidative addition of electron-rich transoid dienes to bromonaphthoquinones
DK2504334T3 (en) PROCEDURE FOR PURIFICATION OF METHYL- {4,6-DIAMINO-2- [1- (2-FLUOROBENZYL) -1H-PYRAZOLO [3,4-B] PYRIDIN-3-YL] PYRIMIDIN-5-YL} METHYL CARBAMATE
FR2557110A1 (fr) Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
IE902657A1 (en) New substituted 1H-indazole-3-carboxamides
EP1546099B1 (en) 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
KR930011038B1 (ko) 테트라하이드로 벤즈이미다졸 유도체 및 이의 제조방법
EP0204349A2 (de) Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
CA2104883A1 (fr) Derives d'acide thienyl ou pyrrolyl carboxyliques, leur preparation et medicaments les contenant
NO175259B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive triazolo-1,4-diazepinforbindelser
US20090082358A1 (en) Vanilloid receptor ligands and their use in treatments
EP3770148A1 (en) Receptor inhibitor, pharmaceutical composition comprising same, and use thereof
AU597996B2 (en) New 1H,3H-pyrrolo{1,2-c}thiazole derivatives, preparation thereof and pharmaceutical compositions containing them
EP2794607B1 (en) Derivatives of aza adamantane and uses thereof
NO163735B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive -carboliner.
FR2631625A1 (fr) Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique
JP3040182B2 (ja) イミダゾピリダジン誘導体、その用途及び製造法
CA2096138A1 (en) .beta.-carboline derivatives their production and use in pharmaceutical agents
NO320332B1 (no) Fremgangsmate ved fremstilling av 2-azadihydroksybicyklo [2.2.2]-heptanforbindelser samt L-tartarsyresalter av forbindelsene
CH630629A5 (fr) Derives de la morphine, leur procede de preparation et leur application comme medicament.
JPS62111983A (ja) １２−および１３−臭素−エルゴリン誘導体、その製法およびこれを含有する抑うつ性疾患症候群の精神障害の治療剤
LU86743A1 (fr) Nouvelles 8a-acylamino-ergolines,leur preparation et leur utilisation comme medicaments
US3086972A (en) Aza-thiaxanthene derivatives
US3882119A (en) Tetracyclic substituted phthalazine compounds